Michael Kelly

Michael Kelly

Direttore/Membro del Consiglio presso PRIME MEDICINE, INC.

Patrimonio netto: 1 M $ in data 31/05/2026

69 anni
Health Technology
Health Services
Commercial Services

Profilo

Michael Anthony Kelly is the founder of Sentry Hill Partners LLC, founded in 2018, where the title held is President.
Current jobs include Independent Director at DMC Global, Inc. since 2020; Lead Independent Director at NeoGenomics, Inc. since 2020; Director at NeoGenomics Laboratories, Inc. since 2020; Independent Director at Prime Medicine, Inc. since 2021; and Director at Chroma Medicine, Inc. since 2023.
Former jobs include Director at Direct Relief; Independent Director at HOOKIPA Pharma, Inc. from 2019 to 2023; Independent Director at Aprea Therapeutics, Inc. from 2020 to 2022; Director at Hookipa Biotech AG from 2019 to 2024; Independent Director at Amicus Therapeutics, Inc. from 2020 to 2026; Senior Vice President-Global Business Services at Amgen, Inc. from 2014 to 2017; Vice President-Finance & Controller at Biogen, Inc. from 1998 to 2000; Chief Financial Officer at Tanox, Inc. from 2000 to 2003; Principal at Onyx Capital Management LLC; Chief Financial Officer & Vice President at The NutraSweet Co. from 1996 to 1998; Chief Financial Officer at Monsanto Life Sciences Co.; and Chief Financial Officer & Vice President-Finance at Nutrasweet Kelco Co. Ltd. from 1996 to 1998.
Education includes undergraduate studies at Florida A&M University.

Partecipazioni note in società pubbliche

SocietàDataNumero di azioniValutazioneData di valutazione
01/06/2026 72.086 ( 0,06% ) 758 345 $ 31/05/2026
13/05/2026 65.590 ( 0,32% ) 446 668 $ 31/05/2026
05/06/2026 0 ( -.--% ) - $ 31/05/2026

Posizioni attive di Michael Kelly

SocietàPosizioneInizio
NEOGENOMICS, INC. Direttore/Membro del Consiglio 15/07/2020
DMC GLOBAL INC. Direttore/Membro del Consiglio 24/07/2020
PRIME MEDICINE, INC. Direttore/Membro del Consiglio 01/11/2021
Direttore/Membro del Consiglio 01/07/2020
Fondatore 01/01/2018
Direttore/Membro del Consiglio 27/09/2023

Precedenti posizioni note di Michael Kelly

SocietàPosizioneFine
AMICUS THERAPEUTICS, INC. Direttore/Membro del Consiglio 27/04/2026
Direttore/Membro del Consiglio 18/11/2024
HOOA PHARPAR Direttore/Membro del Consiglio 07/04/2023
░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░ ░░░░░░░░░░
Vedi nel dettaglio l'esperienza di Michael Kelly

Formazione di Michael Kelly

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

84

Relazioni di 1° grado

19

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private19

Health Technology

Industrial Services

Health Technology

Health Services

Health Technology

Finance

Health Technology

Process Industries

Consumer Services

Commercial Services

Monsanto Life Sciences Co.

Health Technology

Health Services

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

Nutrasweet Kelco Co. Ltd.

  1. Mercati
  2. Insiders
  3. Michael Kelly